Is Elanco Animal Health (ELAN) Still Undervalued As Its Stock Sits At $22.14?

Elanco Animal Health (ELAN) recently caught investor attention after its latest trading session, with the share price closing at $22.14 even as recent month and past 3 months returns show declines.

Zooming out, Elanco Animal Health has a 1-day share price return of 1.70% at $22.14, while the 30-day and 90-day share price returns are down 9.63% and 11.90%, which points to fading short-term momentum even as the 3-year total shareholder return of 131.59% signals a much stronger longer-run journey.

Scan how Elanco Animal Health compares with other potential rebound stories by reviewing a hand picked set of 31 high quality undervalued stocks.

Bulls point to Elanco Animal Health’s strong three year shareholder return and improving annual revenue and net income growth, while bears flag the recent pullback and ongoing losses. Which case does the current valuation lean toward as you weigh the numbers next?

Most Popular Narrative: 29% Undervalued

Elanco Animal Health’s most followed narrative pegs fair value at about $31.21, which sits well above the recent $22.14 close and frames the current debate around its product pipeline, margins, and balance sheet.

Operational focus on product launches and portfolio optimization, including the divestment of non-core businesses like the Aqua division, has helped Elanco reduce debt and increase investment capacity. These moves aim to support higher net margins and greater financial stability as new products scale.

See why 12 investors see Elanco Animal Health as 29% undervalued.

Result: Fair Value of $31.21 (UNDERVALUED)

Still, the Elanco Animal Health story can change quickly if foreign exchange swings pressure its mostly international revenue base, or if new product uptake in clinics stalls.

Find out about the key risks to this Elanco Animal Health narrative.

Next Steps

The mixed tone of the Elanco Animal Health story so far makes this a good moment to move quickly and check the underlying numbers yourself. To see what optimism is already embedded in the data, review the 4 key rewards

Looking for more Elanco Animal Health style investment ideas?

If Elanco Animal Health has you thinking about what else might be hiding in plain sight, use the screener to quickly surface new opportunities before the crowd.

• Target income first and scan for companies with reliable cash returns through a curated set of 7 dividend fortresses.
• Hunt for quality at a discount by reviewing the carefully filtered group of 19 high quality undiscovered gems.
• Prioritise resilience and protect your downside by running through a focused collection of 31 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com